LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.3 USD 1.96% Market Closed
Market Cap: 34.2m USD

LAVA Therapeutics NV
Investor Relations

LAVA Therapeutics NV operates as a biotechnology company, which develops immune oncology biopharmaceutical products. The company is headquartered in Utrecht, Utrecht and currently employs 55 full-time employees. The firm focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.

Show more
Loading

Earnings Calls

No Earnings Calls Available

Management

Mr. Stephen Allen Hurly M.B.A., M.Sc.
CEO, President & Executive Director
No Bio Available
Mr. Fred M. Powell CPA
Chief Financial Officer
No Bio Available
Dr. Hans van der Vliet M.D., Ph.D.
Chief Scientific Officer
No Bio Available
Ms. Amy Garabedian J.D.
General Counsel & Corporate Secretary
No Bio Available
Mr. Wouter van Hunnik
VP & Head of Human Resources
No Bio Available
Dr. Ton Adang Ph.D.
Chief Development Officer
No Bio Available
Dr. Charles Q. Morris M.D., MBChB, MRCP (UK), Ph.D.
Chief Medical Officer
No Bio Available

Contacts

Address
UTRECHT
Utrecht
Yalelaan 60
Contacts